updates

Xareltohcp.com

Visit xareltohcp.com

We collected the majority of metadata history records for Xareltohcp.com. XARELTO Hcp has an elaborated description which rather positively influences the efficiency of search engines index and hence improves positions of the domain. The description and keywords of Xareltohcp were last changed more than a year ago.

Xareltohcp.com metadata updates

Title Description Keywords

July 17, 2018

XARELTO® (rivaroxaban) Information for Healthcare Professionals

XARELTO® is a prescribed treatment indicated for patients with NVAF, DVT/PE, or CAD/PAD. See full Prescribing & Safety Info, including Boxed Warnings.

XARELTO®, rivaroxaban

June 13, 2015

XARELTO® (rivaroxaban) Information for Healthcare Professionals | XARELTO® (rivaroxaban) HCP

Discover XARELTO®, a Factor Xa inhibitor indicated to reduce stroke risk in patients with nonvalvular AF, to treat DVT & PE and for extended risk redu...

xarelto, rivaroxaban, xarelto rivaroxaban, dvt prophylaxis, nonvalvular atrial fibrillatio...

September 17, 2013

XARELTO® (rivaroxaban) | Stroke Risk Reduction in NVAF, DVT and PE Risk Reduction & Prophylaxis

XARELTO® (rivaroxaban) is a Factor Xa inhibitor with six indications including reducing the risk of stroke and systemic embolism in patients with NVAF...

xarelto hcp, rivaroxaban, xarelto indications, atrial fibrillation treatment, blood clot p...

January 21, 2013

XARELTO® (rivaroxaban) | Stroke Risk Reduction in NVAF, DVT and PE Treatment & DVT Prophylaxis

XARELTO® (rivaroxaban) is a factor Xa inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with NVAF. XARELTO® is also i...

xarelto, rivaroxaban, xarelto rivaroxaban, dvt prophylaxis, nonvalvular atrial fibrillatio...

October 19, 2012

XARELTO® (rivaroxaban) | Stroke Prevention in NVAF & DVT Prophylaxis

XARELTO® (rivaroxaban) is a factor Xa inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with NVAF. XARELTO® is also i...

Stroke, stroke prevention, atrial fibrillation, AF, AFib, AFib-related stroke, stroke risk...

July 30, 2012

Official Site - Information for Healthcare Providers | XARELTO® (rivaroxaban) | XARELTOhcp.com

Read about XARELTO® (rivaroxaban tablets), its efficacy and safety from multiple well-controlled clinical trials for FDA-approved uses, and view the f...

Stroke, stroke prevention, atrial fibrillation, AF, AFib, AFib-related stroke, stroke risk...